Insider · CIK 0001264406
Cheryl Beranek
ceoofficerdirector
Files at KTCC (KEY TRONIC CORP), CLFD (Clearfield, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | CLFD Clearfield, Inc. | AGrant or award Common Stock (ESPP) | +210 | $24.78 | $5,204 | 512,041 | Jan 5, 2026 |
| Dec 11, 2025 | CLFD Clearfield, Inc. | GGift Common Stock | -1,960 | $0.00 | $0 | 511,831 | Dec 15, 2025 |
| Nov 28, 2025 | CLFD Clearfield, Inc. | AGrant or award Restricted Stock | +25,545 | $0.00 | $0 | 513,791 | Dec 2, 2025 |
| Nov 20, 2025 | CLFD Clearfield, Inc. | AGrant or award Common Stock | +5,393 | $0.00 | $0 | 480,111 | Nov 24, 2025 |
| Nov 20, 2025 | CLFD Clearfield, Inc. | AGrant or award Restricted Stock | +10,788 | $0.00 | $0 | 490,899 | Nov 24, 2025 |
| Nov 20, 2025 | CLFD Clearfield, Inc. | FTax withholding Common Stock | -2,653 | $28.22 | $75k | 488,246 | Nov 24, 2025 |
| Nov 16, 2025 | CLFD Clearfield, Inc. | FTax withholding Common Stock | -1,020 | $30.72 | $31k | 478,984 | Nov 19, 2025 |
| Nov 16, 2025 | CLFD Clearfield, Inc. | FTax withholding Common Stock | -1,948 | $30.72 | $60k | 477,036 | Nov 19, 2025 |
| Nov 16, 2025 | CLFD Clearfield, Inc. | FTax withholding Common Stock | -2,318 | $30.72 | $71k | 474,718 | Nov 19, 2025 |
| Sep 3, 2025 | KTCC KEY TRONIC CORP | MOption exercise Common Stock | +8,869 | - | - | 10,869 | Sep 5, 2025 |
| Sep 3, 2025 | KTCC KEY TRONIC CORP | MOption exercise Restricted Stock Unitsderivative | +8,869 | $0.00 | $0 | 14,388 | Sep 5, 2025 |
| Aug 21, 2025 | KTCC KEY TRONIC CORP | AGrant or award Restricted Stock Unitsderivative | +14,388 | $0.00 | $0 | 23,257 | Aug 25, 2025 |
| Aug 8, 2025 | CLFD Clearfield, Inc. | MOption exercise Common Stock | +17,776 | $23.74 | $422k | 484,125 | Aug 12, 2025 |
| Aug 8, 2025 | CLFD Clearfield, Inc. | FTax withholding Common Stock | -14,425 | $32.59 | $470k | 469,700 | Aug 12, 2025 |
| Aug 8, 2025 | CLFD Clearfield, Inc. | MOption exercise Common Stock | +24,000 | $12.43 | $298k | 493,700 | Aug 12, 2025 |
| Aug 8, 2025 | CLFD Clearfield, Inc. | FTax withholding Common Stock | -13,696 | $32.59 | $446k | 480,004 | Aug 12, 2025 |
| Aug 8, 2025 | CLFD Clearfield, Inc. | MOption exercise Employee Stock Option (Right to buy)derivative | +17,776 | $0.00 | $0 | 32,797 | Aug 12, 2025 |
| Aug 8, 2025 | CLFD Clearfield, Inc. | MOption exercise Employee Stock Option (Right to buy)derivative | +24,000 | $0.00 | $0 | 8,797 | Aug 12, 2025 |
| Jun 30, 2025 | CLFD Clearfield, Inc. | AGrant or award Common Stock (ESPP) | +197 | $26.35 | $5,191 | 466,349 | Jul 2, 2025 |
| Dec 31, 2024 | CLFD Clearfield, Inc. | AGrant or award Common Stock (ESPP) | +198 | $26.35 | $5,217 | 466,152 | Jan 2, 2025 |
| Dec 5, 2024 | CLFD Clearfield, Inc. | GGift Common Stock | -1,425 | $0.00 | $0 | 466,429 | Dec 10, 2024 |
| Dec 6, 2024 | CLFD Clearfield, Inc. | GGift Common Stock | -475 | $0.00 | $0 | 465,954 | Dec 10, 2024 |
| Nov 26, 2024 | CLFD Clearfield, Inc. | AGrant or award Restricted Stock | +16,181 | $0.00 | $0 | 467,854 | Nov 26, 2024 |
| Nov 16, 2024 | CLFD Clearfield, Inc. | FTax withholding Common Stock | -172 | $28.26 | $4,861 | 454,640 | Nov 19, 2024 |
| Nov 16, 2024 | CLFD Clearfield, Inc. | FTax withholding Common Stock | -1,019 | $28.26 | $29k | 453,621 | Nov 19, 2024 |
| Nov 16, 2024 | CLFD Clearfield, Inc. | FTax withholding Common Stock | -1,948 | $28.26 | $55k | 451,673 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.